
Japan's Largest Pharmaceutical Company Halts Supply of Oseltamivir Amid Flu Outbreak
The current flu season in Japan has brought unprecedented challenges to the country's medical system, with over 9.5 million reported cases and a severe shortage of flu medication, including the antiviral drug Oseltamivir. The shortage has been exacerbated by excessive stockpiling by some medical institutions, leading to uneven distribution of the medication. In response, the Japanese government has called on medical institutions and pharmacies to avoid over-ordering and to consider using alternative medications produced by other companies.


















